Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2681472
rs2681472
0.860 GeneticVariation BEFREE Recently STK39 rs3754777, ATP2B1 rs2681472 and rs17249754 have been associated with BP variation and hypertension. 31242870

2019

dbSNP: rs2681472
rs2681472
A 0.860 GeneticVariation GWASCAT Interethnic analyses of blood pressure loci in populations of East Asian and European descent. 30487518

2018

dbSNP: rs2681472
rs2681472
0.860 GeneticVariation BEFREE The aim of this study was to assess the associations of <i>ATP2B1</i> rs2681472 and <i>CACNB2</i> rs12258967 gene polymorphisms with high blood pressure (HBP) among Lithuanian children and adolescents aged 12-15 years. 29982197

2018

dbSNP: rs2681472
rs2681472
0.860 GeneticVariation BEFREE Recently, a genome-wide association study (GWAS) identified the single-nucleotide polymorphism, rs2681472, as a new hypertension susceptibility genetic variant. 24642721

2014

dbSNP: rs2681472
rs2681472
0.860 GeneticVariation BEFREE The major findings of this study were that four loci--rs10858911, rs2681472, rs17249754 and rs1401982--associated with any or all of four traits: hypertension (P = 0.001-4.6E-05; odds ratio, 0.83-0.87), systolic BP (P = 0.003-0.004), diastolic BP (P = 0.002-0.003) and cf-PWV (P = 0.002-0.004). 23079715

2013

dbSNP: rs2681472
rs2681472
0.860 GeneticVariation BEFREE Association of allelic variants in rs2681472 and rs2681492 with hypertension, rs987237 and rs7826222 with waist circumference and rs864745, rs7578597 and rs2943641 with diabetes were not significant. 23036851

2013

dbSNP: rs2681472
rs2681472
0.860 GeneticVariation BEFREE The results suggested that rs2681472 was significantly associated with hypertension risk in East Asians (OR = 1.18, 95% CI 1.10-1.27, p = 0.000). 22229515

2012

dbSNP: rs2681472
rs2681472
A 0.860 GeneticVariation GWASCAT Genome-wide association study of blood pressure and hypertension. 19430479

2009

dbSNP: rs2681472
rs2681472
A 0.860 GeneticVariation GWASDB Genome-wide association study of blood pressure and hypertension. 19430479

2009

dbSNP: rs1799945
rs1799945
0.840 GeneticVariation BEFREE Compared with WT/WT, H63D</span>/WT and H63D</span>/H6</span>3D participants had a 2% to 4% and 4% to 7% absolute increase in hypertension risk at each visit, respectively. 30571559

2019

dbSNP: rs1799945
rs1799945
0.840 GeneticVariation BEFREE According to GWAS studies, iron regulatory protein HFE gene variant H63D (rs1799945) was associated with hypertension, an observation which we were able to confirm also in our TAMRISK cohort. 28151915

2017

dbSNP: rs1799945
rs1799945
0.840 GeneticVariation BEFREE We found that individuals with the mutated form of the H63D polymorphic site (G-allele) had a 1.4-fold risk (P = 0.037, 95% confidence interval [CI] 1.02-1.89) for hypertension at the age of 50 years compared with the CC genotype carriers. 25634189

2015

dbSNP: rs1799945
rs1799945
0.840 GeneticVariation BEFREE Multivariate analysis revealed that the odds of CHF was higher in females [Odds Ratio (OR) = 2·9, P < 0·01], individuals with pre-HCT chest radiation (OR = 4·7, P = 0·05), hypertension (OR = 2·9, P = 0·01), and with variants of genes coding for the NAD(P)H-oxidase subunit RAC2 (rs13058338, 7508T→A; OR = 2·8, P < 0·01), HFE (rs1799945, 63C→G; OR = 2·5, P = 0·05) or the doxorubicin efflux transporter ABCC2 (rs8187710, 1515G→A; OR = 4·3, P < 0·01). 23927520

2013

dbSNP: rs1799945
rs1799945
G 0.840 GeneticVariation GWASDB Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. 21909115

2011

dbSNP: rs1799945
rs1799945
G 0.840 GeneticVariation GWASCAT Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. 21909115

2011

dbSNP: rs13333226
rs13333226
A 0.810 GeneticVariation GWASCAT Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. 27618447

2016

dbSNP: rs2932538
rs2932538
0.810 GeneticVariation BEFREE SNP rs2932538, a variant in MOV10, was found to be significantly associated with an increased risk of hypertension. 24338417

2013

dbSNP: rs4373814
rs4373814
0.810 GeneticVariation BEFREE However, SNP rs4373814, a variant in CACNB2, showed a relevant association with a decreased risk of hypertension. 24338417

2013

dbSNP: rs6596140
rs6596140
T 0.810 GeneticVariation GWASDB Using a family-based association test, we found an association with SNPs on chromosome 5q31.1 (rs6596140; P<9 × 10(-8)) for hypertension. 22384028

2012

dbSNP: rs6596140
rs6596140
0.810 GeneticVariation BEFREE Using a family-based association test, we found an association with SNPs on chromosome 5q31.1 (rs6596140; P<9 × 10(-8)) for hypertension. 22384028

2012

dbSNP: rs6596140
rs6596140
T 0.810 GeneticVariation GWASCAT Using a family-based association test, we found an association with SNPs on chromosome 5q31.1 (rs6596140; P<9 × 10(-8)) for hypertension. 22384028

2012

dbSNP: rs2932538
rs2932538
G 0.810 GeneticVariation GWASDB Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. 21909115

2011

dbSNP: rs2932538
rs2932538
G 0.810 GeneticVariation GWASCAT Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. 21909115

2011

dbSNP: rs4373814
rs4373814
G 0.810 GeneticVariation GWASDB Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. 21909115

2011

dbSNP: rs4373814
rs4373814
G 0.810 GeneticVariation GWASCAT Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. 21909115

2011